Bio Green Med Solution, Inc. Annual Report - How They Did This Year

I’ve put together this guide to help you understand how Bio Green Med Solution, Inc. (BGMS) performed this year. My goal is to translate complex financial filings into plain English so you can decide if this company fits your investment goals.

1. What does this company do?

Bio Green Med Solution operates in three areas: fire safety equipment and maintenance, safety apparel, and clinical trial supplies. They balance steady, practical safety services with the specialized world of medical research.

They operate globally across the U.S., Malaysia, and the U.K. Their fire safety division provides steady income through long-term maintenance contracts, while their clinical trial segment manages logistics for medical supplies used by mid-sized pharmaceutical firms.

2. Financial performance and health

The company is currently in a fragile financial position. For the year ending December 31, 2025, they lost $4.2 million on $12.8 million in revenue. Because of their history of losses, the company has noted substantial doubt regarding their ability to continue as a going concern. They are not currently generating enough profit to cover their operating costs.

To maintain operations, they rely on selling new shares of stock. In 2025, they raised $3.5 million through this method. While this provides immediate liquidity, it results in "dilution," which reduces your ownership percentage and the value of your stake. As of their latest filing, they held $850,000 in cash. At their current spending rate, this capital is expected to be exhausted within 6 to 9 months.

3. Major risks: What could go wrong?

The company faces several significant challenges:

• Survival Risk: They burn through $3.8 million in cash annually. They must secure additional funding by the third quarter of 2026 to continue operations.
• Dilution: The number of shares grew by 22% last year to fund operations, which reduces the value of existing shares.
• Market Competition: Their products are treated as commodities, limiting their ability to raise prices. Their 18% profit margin leaves little room to absorb rising costs.
• Operational Hurdles: They are exposed to risks from global trade policies and currency fluctuations between the U.S. dollar, Malaysian ringgit, and British pound. Additionally, 15% of their customer invoices are over 90 days late, which creates pressure on their cash flow.

4. The Bottom Line

As of March 2026, the company had approximately 5.5 million shares outstanding. While they maintain diverse business lines, they are currently in "survival mode" and rely heavily on outside capital to remain operational.

For a regular investor, this is a high-risk situation. You are betting on their ability to turn operations around before their cash reserves are depleted. Without securing high-profit contracts or significantly lowering costs, the company will likely need to issue more shares to raise capital in the coming year.

Investor Tip: Before investing, ask yourself if you are comfortable with the high probability of further share dilution and the company's stated uncertainty regarding its long-term survival. If you prefer companies with established profitability and cash reserves, this may not be the right fit for your portfolio.